These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2469471)
1. Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. James RW; Proudfoot A; Pometta D Biochim Biophys Acta; 1989 Apr; 1002(3):292-301. PubMed ID: 2469471 [TBL] [Abstract][Full Text] [Related]
2. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma. Nichols AV; Blanche PJ; Shore VG; Gong EL Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827 [TBL] [Abstract][Full Text] [Related]
3. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. Kempen HJ; van Gent CM; Buytenhek R; Buis B J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880 [TBL] [Abstract][Full Text] [Related]
4. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins. Cheung MC; Wolf AC J Lipid Res; 1989 Apr; 30(4):499-509. PubMed ID: 2502592 [TBL] [Abstract][Full Text] [Related]
5. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Marcel YL; Weech PK; Nguyen TD; Milne RW; McConathy WJ Eur J Biochem; 1984 Sep; 143(3):467-76. PubMed ID: 6479161 [TBL] [Abstract][Full Text] [Related]
6. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux. Cheung MC; Mendez AJ; Wolf AC; Knopp RH J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861 [TBL] [Abstract][Full Text] [Related]
7. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma. Cheung MC; Wolf AC; Illingworth DR Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297 [TBL] [Abstract][Full Text] [Related]
8. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1. Greilberger J; Jürgens G Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):185-91. PubMed ID: 9512478 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles. Hennessy LK; Kunitake ST; Kane JP Biochemistry; 1993 Jun; 32(22):5759-65. PubMed ID: 8504094 [TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunoabsorbant assay of apolipoprotein AII in plasma, with use of a monoclonal antibody. Stein EA; DiPersio L; Pesce AJ; Kashyap M; Kao JT; Srivastava L; McNerney C Clin Chem; 1986 Jun; 32(6):967-71. PubMed ID: 3085983 [TBL] [Abstract][Full Text] [Related]
11. Protein transfer between A-I-containing lipoprotein subpopulations: evidence of non-transferable A-I in particles with A-II. Cheung MC; Wolf AC; Knopp RH; Foster DM Biochim Biophys Acta; 1992 Nov; 1165(1):68-77. PubMed ID: 1420350 [TBL] [Abstract][Full Text] [Related]
12. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. Cheung MC; Brown BG; Wolf AC; Albers JJ J Lipid Res; 1991 Mar; 32(3):383-94. PubMed ID: 1906084 [TBL] [Abstract][Full Text] [Related]
13. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia. Tilly-Kiesi M; Tikkanen MJ J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316 [TBL] [Abstract][Full Text] [Related]
14. Effect of the human cholesteryl ester transfer protein on the particle size redistribution of specific subpopulations of high density lipoproteins-3. Lagrost L Biochim Biophys Acta; 1992 Jun; 1126(2):143-50. PubMed ID: 1627616 [TBL] [Abstract][Full Text] [Related]
15. Characterization of high density lipoprotein binding to human adipocyte plasma membranes. Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332 [TBL] [Abstract][Full Text] [Related]
16. Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. James RW; Pometta D Atherosclerosis; 1990 Jul; 83(1):35-45. PubMed ID: 2117929 [TBL] [Abstract][Full Text] [Related]
17. The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells. Vadiveloo PK; Fidge NH Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):145-51. PubMed ID: 1599393 [TBL] [Abstract][Full Text] [Related]
18. Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107-->0). Tilly-Kiesi M; Lichtenstein AH; Rintarahko J; Taskinen MR Atherosclerosis; 1998 Mar; 137(1):37-47. PubMed ID: 9568735 [TBL] [Abstract][Full Text] [Related]
19. Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII. James RW; Pometta D J Lipid Res; 1994 Sep; 35(9):1583-91. PubMed ID: 7806972 [TBL] [Abstract][Full Text] [Related]
20. Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. James RW; Hochstrasser D; Tissot JD; Funk M; Appel R; Barja F; Pellegrini C; Muller AF; Pometta D J Lipid Res; 1988 Dec; 29(12):1557-71. PubMed ID: 3149664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]